Reaction Details |
| Report a problem with these data |
Target | Beta-3 adrenergic receptor |
---|
Ligand | BDBM50106811 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_39052 |
---|
Ki | 220±n/a nM |
---|
Citation | Washburn, WN; Sher, PM; Poss, KM; Girotra, RN; McCann, PJ; Gavai, AV; Mikkilineni, AB; Mathur, A; Cheng, P; Dejneka, TC; Sun, CQ; Wang, TC; Harper, TW; Russell, AD; Slusarchyk, DA; Skwish, S; Allen, GT; Hillyer, DE; Frohlich, BH; Abboa-Offei, BE; Cap, M; Waldron, TL; George, RJ; Tesfamariam, B; Ciosek, CP; Ryono, D; Young, DA; Dickinson, KE; Seymour, AA; Arbeeny, CM; Gregg, RE Beta 3 agonists. Part 1: evolution from inception to BMS-194449. Bioorg Med Chem Lett11:3035-9 (2001) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-3 adrenergic receptor |
---|
Name: | Beta-3 adrenergic receptor |
Synonyms: | ADRB3 | ADRB3R | ADRB3_HUMAN | B3AR | Beta-2 adrenergic receptor and beta-3 adrenergic receptor | Beta-3 adrenoceptor | Beta-3 adrenoreceptor | adrenergic Beta3 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 43534.88 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 408 |
Sequence: | MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIV
AIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLC
VTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRV
GADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRG
ELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGT
FTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLL
CRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS
|
|
|
BDBM50106811 |
---|
n/a |
---|
Name | BDBM50106811 |
Synonyms: | 2-[(R)-2-Hydroxy-2-(4-hydroxy-3-methanesulfonylamino-phenyl)-ethylamino]-2,2-bis-(4-methoxy-phenyl)-acetamide | CHEMBL102759 |
Type | Small organic molecule |
Emp. Form. | C25H29N3O7S |
Mol. Mass. | 515.579 |
SMILES | COc1ccc(cc1)C(NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1)(C(N)=O)c1ccc(OC)cc1 |
Structure |
|